Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Preclinical studies support use of MT-103 for chronic lymphocytic leukemia

July 1, 2003

CPMP hands down positive opinion for survival claim for MabCampath

June 30, 2003

Preliminary findings for Ceplene in stage IV malignant melanoma

June 26, 2003

Phase III Theratope vaccine trial fails to meet primary endpoints

June 19, 2003

Interferon alfa variants with enhanced immunomodulatory and antitumor activity

June 17, 2003

Dendreon's phase III trial will serve as basis for Provenge approval

June 17, 2003

Preliminary evidence of immune response reported in Norelin trial

June 16, 2003

3M submits sNDA for Aldara in superficial basal cell carcinoma

June 13, 2003

Preclinical efficacy of a humanized anti-CD20 monoclonal antibody against NHL

June 13, 2003

MedImmune and Micromet to codevelop MT-103

June 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...